Lebrikizumab's Real-World Results: Two Mexican AD Cases Reported
Two moderate-to-severe atopic dermatitis patients in Mexico improved on lebrikizumab in routine practice, per a Cureus case report adding real-world IL-13 inhibitor evidence.
Topic
Il 13 Inhibitor
Topic
Il 13 Inhibitor
Lebrikizumab Improves Hand and Foot Atopic Dermatitis in Phase 3b Trial
Phase 3b trial data show lebrikizumab improves hand and foot atopic dermatitis, giving clinicians trial-based evidence in a hard-…
Zumilokibart Hits Primary Endpoint in APEX Part B Atopic Dermatitis Trial
Zumilokibart met the primary endpoint in Part B of the APEX atopic dermatitis trial, HCPLive reports, setting up a potential Phas…